| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 1988 | The Amplification Refractory Mutation System (ARMS):a Rapid and Direct Prenatal Diagnostic Technique for β-thalassemia in Singapore | Tan, J. A. M. A.; Tay, J. S. H.; Lin, Liang-In; Wong, H. B.; Tan, J. A. M. A.; Tay, J. S. H.; 林亮音; Kham, S. K. Y.; Chia, J. N.; CHin, T. M.; Aziz, N. B. A.; Wong, H. B. | Prenatal Diagnosis | | | |
| 2016 | Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission | Wang, Yu-Ming; Lu, Jeng-Wei; Lin, Chang-Chi; Chin, Yuan-Fan; Wu, Tzong-Yuan; Lin, Liang-In; Lai, Zheng-Zong; Kuo, Szu-Cheng; Ho, Yi-Jung | Antiviral Research | | | |
| 2021 | Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort | Chen, Kuo-Hsing; Lin, Liang-In; Yuan, Chang-Tsu; Tseng, Li-Hui; Chao, Yu-Liang; Liang, Yi-Hsin; Liang, Jin-Tung; BEEN-REN LIN ; Cheng, Ann-Lii; Yeh, Kun-Huei | British journal of cancer | | | |
| 2021 | Cabozantinib promotes erythroid differentiation in K562 erythroleukemia cells through global changes in gene expression and JNK activation | Fu, Yu-Hsuan; Ou, Da-Liang; Yang, Yi-Ru; Su, Kuan-Wei; Chen, Chien-Yuan; HWEI-FANG TIEN ; Lai, Zheng-Sheng; Shen, Che-Kun James; Chien, Hsiung-Fei; Lin, Liang-In | Cancer gene therapy | | | |
| 1991 | Cell Type-specific Protein-DNA Interactions in the Human ζ-globin Upstream Promoter Region:Displacement of Sp1 by the Erythroid Cell- specific Factor NF-E1 | Chen, J.; Lin, Liang-In; Tam, M.; Shen, C. K. J.; Yu, C. Y.; Chen, J.; 林亮音; Tam, M.; Shen, C. K. J. | Molecular and Cellular Biology | | | |
| 2015 | Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations | Liang, Yi-Hsin; Lin, Yu-Lin; Liau, Jau-Yu; Tsai, Jia-Huei; Liang, Jin-Tung; Lin, Been-Ren; Hung, Ji-Shiang; Tseng, Li-Hui; Lin, Liang-In; Chang, Yih-Leong; Cheng, Ann-Lii; Yeh, Kun-Huei | Anticancer Res. | | | |
| 2005 | Characterization of Cebpa Mutations in Acute Myeloid Leukemia: Most Patients with Cebpa Mutations Have Biallelic Mutations and Show a Distinct Immunophenotype of the Leukemic Cells | LIN, LIANG-IN; CHEN, CHIEN-YUAN; LIN, DONG-TSAMN; TSAY, WOEI; TANG, JIH-LUH; SHEN, HWEI-LING; YAO, MING; HUANG, SHENG-YI; TIEN, HWEI-FANG | CLINICAL CANCER RESEARCH | | | |
| 2008 | Clinical and Biological Characterization of Adult Patients with Acute Myeloid Leukemia Bearing T(7;11)(P15;P15)-Analysis of 536 Patients | CHOU, WEN-CHIEN; CHEN, CHIEN-YUAN; HOU, HSIN-AN; LIN, LIANG-IN; TANG, JIH-LUH; YAO, MING; TSAY, WOEI; TIEN, HWEI-FANG | BLOOD | | | |
| 2015 | Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus | LEE-MING CHUANG; Huang, Jean; Chen, Kuo-Hsing; Lin, Yu-Lin; Ou, Horng-Yih; Ou, Horng-Yih; Liau, Jau-Yu; Karnchanasorn, Rudruidee; Karnchanasorn, Rudruidee; Tsai, Jia-Huei; Samoa, Raynald; Tseng, Li-Hui; Chuang, Lee-Ming; Chuang, Lee-Ming; Chiu, Ken C.; Lin, Liang-In; Liang, Jin-Tung; Feng, Wei; Lin, Been-Ren; Hung, Ji-Shiang; Chang, Yih-Leong; Yeh, Kun-Huei; Cheng, Ann-Lii; 林亮音; 曾麗慧; 張逸良; 林育麟; 鄭安理; 葉坤輝; 蔡佳惠; 陳國興; 洪基翔; 林本仁; 廖肇裕; 梁金銅 | Endocrine | | | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; Lin, Liang-In; WEN-CHIEN CHOU ; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang; MING YAO | Blood advances | | | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO ; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang | Blood advances | | | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; TIEN FENG-MING; Kuo, Yuan-Yeh; Wu, Dung-Chi; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang | Blood advances | | | |
| 2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | Tien, Feng-Ming; Hou, Hsin-An; Tang, Jih-Luh; Kuo, Yuan-Yeh; Chen, Chien-Yuan; Tsai, Cheng-Hong; Yao, Ming; Lin, Chien-Ting; Li, Chi-Cheng; Huang, Shang-Yi; Ko, Bor-Sheng; Hsu, Szu-Chun; Wu, Shang-Ju; Liu, Jia-Hau; Chou, Sheng Chieh; Tsay, Woei; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; Lin, Liang-In; Chou, Wen-Chien; Tien, Hwei-Fang; CHI-TE LIU | Haematologica | | | |
| 2016 | Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression | Hsu, Chiun; Lin, Liang-In; Cheng, Yu-Che; Feng, Zi-Rui; Shao, Yu-Yun; Cheng, Ann-Lii; Ou, Da-Liang | Clinical Cancer Research | | | |
| 2019 | Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib | Ko, Ya-Chen; Hu, Chung-Yi; Liu, Zheng-Hau; Tien, Hwei-Fang; Ou, Da-Liang; Chien, Hsiung-Fei; Lin, Liang-In | International journal of molecular sciences | | | |
| 2015 | Deoxyinosine repair in nuclear extracts of human cells | YA-CHIEN YANG; Lee, Chia-Chia; Yang, Ya-Chien; WOEI-HORNG FANG; LIANG-IN LIN; Goodman, Steven D.; Chen, Shi; Huang, Teng-Yung; Cheng, Wern-Cherng; Lin, Liang-in; Fang, Woei-horng | Cell and Bioscience | | | |
| 2021 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU ; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang | Bone marrow transplantation | | | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang | Bone marrow transplantation | | | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | Tien, Feng-Ming; Tsai, Cheng-Hong; Huang, Sheng-Chuan; Liu, Jia-Hau; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; WEN-CHIEN CHOU ; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang | Bone marrow transplantation | | | |
| 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; HWEI-FANG TIEN | Bone marrow transplantation | | | |
